| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 13 | -133K | 100% | $9.20 | -$1.22M |
| Net | -13 | -133K | -100% | -$1.22M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Matthew C. Kapusta | CEO, Managing Director, Director | $6.7M | -$680K | -9.21% | Mar 3, 2025 |
| Christian Klemt | Chief Financial Officer | $2.24M | -$315K | -12.3% | Mar 3, 2025 |
| Walid Abi-Saab | Chief Medical Officer | $1.56M | -$20.2K | -1.28% | Mar 3, 2025 |
| Jeannette Potts | Chief Legal Officer | $1.23M | -$96.6K | -7.27% | Mar 3, 2025 |
| Ricardo Dolmetsch | President, R&D | $1.22M | Sep 18, 2023 | ||
| Alexander Edward Kuta III | Executive VP, Operations | $674K | Mar 7, 2023 | ||
| Pierre Caloz | Chief Operating Officer | $557K | -$14.1K | -2.47% | Jun 17, 2024 |
| Robert Gut | Director | $251K | -$17.9K | -6.66% | Jun 19, 2024 |
| Madhavan Balachandran | Director | $153K | -$11.4K | -6.94% | Jun 19, 2024 |
| Jeremy P. Springhorn | Director | $153K | -$11.4K | -6.94% | Jun 19, 2024 |
| David D. Meek | Director | $136K | -$11.4K | -7.73% | Jun 19, 2024 |
| Leonard Post | Director | $116K | -$11.4K | -8.98% | Jun 19, 2024 |
| Rachelle Suzanne Jacques | Director | $108K | -$11.4K | -9.55% | Jun 19, 2024 |
| Paula Soteropoulos | Director | $104K | -$11.4K | -9.9% | Jun 13, 2024 |
| Jack Kaye | Director | $70.1K | -$11.4K | -14% | Jun 19, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|